Literature DB >> 17409384

The lysine-specific demethylase 1 is required for cell proliferation in both p53-dependent and -independent manners.

Ariane Scoumanne1, Xinbin Chen.   

Abstract

The lysine-specific demethylase 1 (LSD1), a component of several histone deacetylase complexes, plays an important role in chromatin remodeling and transcriptional regulation. Here, we generated multiple cell lines in which LSD1 is inducibly expressed or knocked down and found that LSD1 is required for cell proliferation. In addition, we found that deficiency in LSD1 leads to a partial cell cycle arrest in G(2)/M and sensitizes cells to growth suppression induced by DNA damage or MDM2 inhibition in a p53-dependent manner. We also showed that LSD1 deficiency delays p53 stabilization induced by DNA damage, leading to a delayed induction of p21 and MDM2. Finally, we performed a microarray study and identified several novel LSD1 target genes, including S100A8, which encodes a calcium-binding protein, and DEK, a proto-oncogene. Taken together, we uncovered that LSD1 has a pro-oncogenic function by modulating pro-survival gene expression and p53 transcriptional activity.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17409384     DOI: 10.1074/jbc.M701023200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  57 in total

1.  KDM8, a H3K36me2 histone demethylase that acts in the cyclin A1 coding region to regulate cancer cell proliferation.

Authors:  Datsun A Hsia; Clifford G Tepper; Mamata R Pochampalli; Elaine Y C Hsia; Chie Izumiya; Steve B Huerta; Michael E Wright; Hong-Wu Chen; Hsing-Jien Kung; Yoshihiro Izumiya
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-10       Impact factor: 11.205

2.  Dynamic interaction between TAL1 oncoprotein and LSD1 regulates TAL1 function in hematopoiesis and leukemogenesis.

Authors:  Y Li; C Deng; X Hu; B Patel; X Fu; Y Qiu; M Brand; K Zhao; S Huang
Journal:  Oncogene       Date:  2012-02-06       Impact factor: 9.867

3.  Lysine-specific histone demethylase 1 inhibitors control breast cancer proliferation in ERα-dependent and -independent manners.

Authors:  Julie A Pollock; Michelle D Larrea; Jeff S Jasper; Donald P McDonnell; Dewey G McCafferty
Journal:  ACS Chem Biol       Date:  2012-05-10       Impact factor: 5.100

Review 4.  Intersection of nuclear receptors and the proteasome on the epigenetic landscape.

Authors:  H Karimi Kinyamu; Wendy N Jefferson; Trevor K Archer
Journal:  Environ Mol Mutagen       Date:  2008-01       Impact factor: 3.216

5.  LSD1 is Required for Hair Cell Regeneration in Zebrafish.

Authors:  Yingzi He; Dongmei Tang; Chengfu Cai; Renjie Chai; Huawei Li
Journal:  Mol Neurobiol       Date:  2015-05-26       Impact factor: 5.590

Review 6.  Histone demethylases and cancer.

Authors:  Sotirios C Kampranis; Philip N Tsichlis
Journal:  Adv Cancer Res       Date:  2009       Impact factor: 6.242

7.  Relationship between LSD1 expression and E-cadherin expression in prostate cancer.

Authors:  Min Wang; Xiuheng Liu; Guanjun Jiang; Hui Chen; Jia Guo; Xiaodong Weng
Journal:  Int Urol Nephrol       Date:  2015-01-28       Impact factor: 2.370

8.  Pure Diastereomers of a Tranylcypromine-Based LSD1 Inhibitor: Enzyme Selectivity and In-Cell Studies.

Authors:  Sergio Valente; Veronica Rodriguez; Ciro Mercurio; Paola Vianello; Bruna Saponara; Roberto Cirilli; Giuseppe Ciossani; Donatella Labella; Biagina Marrocco; Giovanni Ruoppolo; Oronza A Botrugno; Paola Dessanti; Saverio Minucci; Andrea Mattevi; Mario Varasi; Antonello Mai
Journal:  ACS Med Chem Lett       Date:  2014-12-08       Impact factor: 4.345

Review 9.  Cellular analysis of the action of epigenetic drugs and probes.

Authors:  Mirjam Hau; Fides Zenk; A Ganesan; Nicola Iovino; Manfred Jung
Journal:  Epigenetics       Date:  2017-01-10       Impact factor: 4.528

10.  PRMT5 is required for cell-cycle progression and p53 tumor suppressor function.

Authors:  A Scoumanne; J Zhang; X Chen
Journal:  Nucleic Acids Res       Date:  2009-06-15       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.